Paul Oskar General Manager van Geneesmiddelenveiligheid MPI Research
Array
Paul Oskar III is toegetreden tot MPI Research, de wereldwijd grootste op één locatie gevestigde organisatie voor preklinisch contractonderzoek, als Vice President en General Manager van Geneesmiddelenveiligheid en Preklinische wetenschappen. De afgelopen tien jaar heeft Oskar diverse leidinggevende functies vervuld bij Charles River Laboratories (CRL), het meest recent als Corporate Vice President van Global Primate Supply.
Hij werkte bij CRL ook als Corporate Vice President van Global Discovery Services, Corporate Vice President van Specialty Preclinical Services, Corporate Vice President en President van US Preclinical Services, en General Manager van Preclinical Services op de locatie Worcester.
Engelstalig bericht:
Paul Oskar III has joined MPI Research, the largest single-site preclinical contract research organization worldwide, as Vice President, General Manager of Drug Safety and Preclinical Sciences.
Paul Oskar III (Photo: Business Wire)
Over the past decade, Oskar has held numerous leadership positions with Charles River Laboratories (CRL), most recently as Corporate Vice President, Global Primate Supply. At CRL, he has also held the positions of Corporate Vice President of Global Discovery Services, Corporate Vice President of Specialty Preclinical Services, Corporate Vice President and President of US Preclinical Services, and General Manager of Preclinical Services at the Worcester site. He began his career at CRL’s Research Animal Diagnostic Services Laboratory, ultimately serving as Executive Director responsible for all laboratory operations. During his time at CRL, Oskar consistently grew sales and profits, expanded laboratory space and implemented cutting edge technology. Oskar received his MBA from the University of Massachusetts and his BA in Zoology from the University of Rhode Island.
MPI Research President and COO, Tim Derrington says, “Paul has the robust experience in CRO management that will even further strengthen the industry footprint and operating capabilities of MPI Research. His proven success in implementing new technologies and capital project management, and his extensive background in building operational efficiencies and other key corporate functions will add breadth and depth to our leadership team, and enable us to continue to meet the expectations of our growing customer base.â€
Please join us in welcoming Paul Oskar to MPI Research!
MPI Research, with global headquarters in Mattawan, Michigan, provides safety evaluation, discovery, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world. Learn more about how we can exceed your expectations at www.mpiresearch.com.
